ArticlePediatric research2018

Menkes disease: Oral administration of glyoxal-bis(N(4)-methylthiosemicarbazonato)-copper(II) rescues the macular mouse.

Mitsutoshi Munakata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.